MetaCap

Lite Strategy Statistics

NASDAQ: LITSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.8026-0.0337 (-4.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Lite Strategy by the numbers

Lite Strategy has a market capitalization of $24.0 million based on 29.88M shares outstanding. With trailing EPS of $-1.38, Lite Strategy is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.6% below its 50-day average and 24.9% below its 200-day average.

Average daily trading volume is 524.33K shares, or about $420,829 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LITS valuation vs. peer median

LITS compared with the median of 8 peer companies
MetricLITSPeer medianDifference
Market cap$23.99M$23.35M+3%
Avg. volume524.33K108.88K+382%

Peer median across 8 companies: SCYX, ABVC, IXHL, RMTI, IMMP, CRVO, BCTX, TELO.

Valuation

Price and trading

Previous close
0.8363
Open
0.84
Day range
0.7901 – 0.865
52-week range
0.69 – 1.99
52-week change
-52.79%
Beta
—
Volume
177.44K

Dividends and events

Annual dividend
None
Next earnings date
Sep 29, 2026

Additional statistics

Market Cap
23.99M
Eps
-1.38
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.99
Week52 Low
0.69
Avg Volume
524.33K
Shares Outstanding
29.88M
Ma50
1.14
Ma200
1.07
Earnings Date
Sep 29, 2026
Pct From52w High
-59.67%
Pct From52w Low
16.32%

Related